Jane Street’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,600
Closed -$236K 9654
2023
Q2
$236K Sell
5,600
-71,700
-93% -$2.9M ﹤0.01% 7468
2023
Q1
$2.75M Buy
77,300
+51,500
+200% +$1.87M ﹤0.01% 3289
2022
Q4
$946K Buy
25,800
+18,700
+263% +$739K ﹤0.01% 5070
2022
Q3
$335K Buy
+7,100
New +$459K ﹤0.01% 7403
2022
Q2
Sell
-9,700
Closed -$785K 11296
2022
Q1
$785K Buy
+9,700
New +$821K ﹤0.01% 6627
2021
Q3
Sell
-2,400
Closed -$215K 11015
2021
Q2
$215K Sell
2,400
-21,200
-90% -$1.79M ﹤0.01% 8704
2021
Q1
$1.79M Buy
23,600
+9,000
+62% +$679K ﹤0.01% 4231
2020
Q4
$995K Buy
+14,600
New +$910K ﹤0.01% 4663
2020
Q3
Sell
-38,600
Closed -$2.25M 8166
2020
Q2
$2.25M Buy
+38,600
New +$2.07M ﹤0.01% 2904

Other funds holding SYNH

Jane Street's SYNH Position: Q3 2023 in Review

Jane Street sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 449,573 shares — an estimated $18.9M sold.

Jane Street first reported a position in SYNH in Q3 2017 and held it in 19 quarters. The position peaked at $18.9M in Q2 2023. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Jane Street reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Jane Street sold 449,573 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $18.9M.
  • Jane Street first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 19 quarters.
  • Jane Street's Syneos Health, Inc. Class A Common Stock position peaked at $18.9M in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Jane Street's 13F filing for Q3 2023, filed 15 Nov 2023.